UB Paderborn / Katalog / Suche / in CDI

Patients’ perspective on the burden of migraine in Europe: a cross-sectional analysis of survey data in France, Germany, Italy, Spain, and the United Kingdom

Journal of headache and pain, 2018-09, Vol.19 (1), p.82-11, Article 82

2018

Link zum Volltext

Verfügbarkeit prüfen

Impact of erenumab on acute medication usage and health care resource utilization among migraine patients: a US claims database study

Journal of headache and pain, 2021-04, Vol.22 (1), p.27-27, Article 27

2021

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of exacerbations and blood eosinophils in UK and US COPD populations

Respiratory research, 2019-08, Vol.20 (1), p.178-178, Article 178

2019

Link zum Volltext

Verfügbarkeit prüfen

Physician-reported Clinical Unmet Needs, Burden and Treatment Patterns of Paediatric Psoriasis Patients: A US and EU Real-world Evidence Study

Acta dermato-venereologica, 2022-02, Vol.102, p.adv00660-adv00660

2022

Link zum Volltext

Verfügbarkeit prüfen

The Humanistic and Economic Burden of Migraine in Europe: A Cross-Sectional Survey in Five Countries

Neurology and therapy, 2020-12, Vol.9 (2), p.535-549

2020

Link zum Volltext

Verfügbarkeit prüfen

Associations Between Headache-Free Days and Patient-Reported Outcomes Among Migraine Patients: A Cross-Sectional Analysis of Survey Data in Europe

Pain and therapy, 2019-12, Vol.8 (2), p.203-216

2019

Link zum Volltext

Verfügbarkeit prüfen

Effect of interferon beta-1a subcutaneously three times weekly on clinical and radiological measures and no evidence of disease activity status in patients with relapsing-remitting multiple sclerosis at year 1

BMC neurology, 2018-09, Vol.18 (1), p.143-143, Article 143

2018

Link zum Volltext

Verfügbarkeit prüfen

Burden of Migraine in Europe Using Self-Reported Digital Diary Data from the Migraine Buddy© Application

Neurology and therapy, 2018-12, Vol.7 (2), p.321-332

2018

Link zum Volltext

Verfügbarkeit prüfen

Comparative effectiveness of erenumab versus oral preventive medications among migraine patients: A US claims database study

Cephalalgia reports, 2021, Vol.4, p.251581632110400

2021

Link zum Volltext

Verfügbarkeit prüfen

Assessment of the pharmacokinetics of co‐administered maraviroc and raltegravir

British journal of clinical pharmacology, 2010-01, Vol.69 (1), p.51-57

2010

Link zum Volltext

Verfügbarkeit prüfen

Predictive value of early magnetic resonance imaging measures is differentially affected by the dose of interferon beta-1a given subcutaneously three times a week: an exploratory analysis of the PRISMS study

BMC neurology, 2018-05, Vol.18 (1), p.68-68, Article 68

2018

Link zum Volltext

Verfügbarkeit prüfen

Hemodynamic effects of single-dose vardenafil in subjects receiving maraviroc

Journal of acquired immune deficiency syndromes (1999), 2010-07, Vol.54 (3), p.336

2010

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetic interactions between lersivirine and zidovudine, tenofovir disoproxil fumarate/ emtricitabine and abacavir/lamivudine

Antiviral therapy, 2013, Vol.18 (6), p.745-754

2013

Link zum Volltext

Verfügbarkeit prüfen

Potent protection of ferulic acid against excitotoxic effects of maternal intragastric administration of monosodium glutamate at a late stage of pregnancy on developing mouse fetal brain

European neuropsychopharmacology, 2006-04, Vol.16 (3), p.170-177

2006

Link zum Volltext

Verfügbarkeit prüfen

33991 Predictors of response to secukinumab in patients with moderate to severe plaque psoriasis with special area involvement in real-world clinical setting: A pooled analysis of prospective observational studies PROSPECT, SERENA, and REALIA

Journal of the American Academy of Dermatology, 2022-09, Vol.87 (3), p.AB193-AB193

2022

Link zum Volltext

Verfügbarkeit prüfen

Uncontrolled asthma across GINA treatment steps 2 − 5 in a large US patient cohort

The Journal of asthma, 2022-05, Vol.59 (5), p.1051-1062

2022

Link zum Volltext

Verfügbarkeit prüfen

Real-world treatment satisfaction with erenumab in migraine: analysis of the US National Health and Wellness Survey

Current medical research and opinion, 2023-12, Vol.ahead-of-print (ahead-of-print), p.1-7

2023

Link zum Volltext

Verfügbarkeit prüfen

P254 Secukinumab retention and safety in patients with active psoriatic arthritis or ankylosing spondylitis: two-year interim results of the observational SERENA study

Rheumatology (Oxford, England), 2022-04, Vol.61 (Supplement_1)

2022

Link zum Volltext

Verfügbarkeit prüfen

Employee and Employer Benefits From a Migraine Management Program: Disease Outcomes and Cost Analysis

Headache, 2020-10, Vol.60 (9), p.1947-1960

2020

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness of erenumab and onabotulinumtoxinA on acute medication usage and health care resource utilization as migraine prevention in the United States

Journal of managed care & specialty pharmacy, 2021-09, Vol.27 (9), p.1157

2021

Link zum Volltext

Verfügbarkeit prüfen

Comparison of pharmacokinetic variability of fesoterodine vs. tolterodine extended release in cytochrome P450 2D6 extensive and poor metabolizers

British journal of clinical pharmacology, 2011-08, Vol.72 (2), p.226-234

2011

Link zum Volltext

Verfügbarkeit prüfen

Early MRI results and odds of attaining ‘no evidence of disease activity’ status in MS patients treated with interferon β-1a in the EVIDENCE study

Journal of the neurological sciences, 2017-08, Vol.379, p.151-156

2017

Link zum Volltext

Verfügbarkeit prüfen

Correction to: Real-World Trends in Characteristics of Patients with Migraine Newly Initiated on Erenumab in the USA: A Retrospective Analysis

Advances in therapy, 2021-08, Vol.38 (8), p.4598-4598

2021

Link zum Volltext

Verfügbarkeit prüfen

Health Care Utilization and Costs in Patients With Migraine Who Have Failed Previous Preventive Treatments

Neurology. Clinical practice, 2021-06, Vol.11 (3), p.206-215

2021

Link zum Volltext

Verfügbarkeit prüfen

Correction to: Real-World Trends in Characteristics of Patients with Migraine Newly Initiated on Erenumab in the USA: A Retrospective Analysis

Advances in therapy, 2021-06, Vol.38 (6), p.2935-2935

2021

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Patients’ perspective on the burden of migraine in Europe: a cross-sectional analysis of survey data in France, Germany, Italy, Spain, and the United Kingdom

Impact of erenumab on acute medication usage and health care resource utilization among migraine patients: a US claims database study

Evaluation of exacerbations and blood eosinophils in UK and US COPD populations

Physician-reported Clinical Unmet Needs, Burden and Treatment Patterns of Paediatric Psoriasis Patients: A US and EU Real-world Evidence Study

The Humanistic and Economic Burden of Migraine in Europe: A Cross-Sectional Survey in Five Countries

Associations Between Headache-Free Days and Patient-Reported Outcomes Among Migraine Patients: A Cross-Sectional Analysis of Survey Data in Europe

Effect of interferon beta-1a subcutaneously three times weekly on clinical and radiological measures and no evidence of disease activity status in patients with relapsing-remitting multiple sclerosis at year 1

Burden of Migraine in Europe Using Self-Reported Digital Diary Data from the Migraine Buddy© Application

Comparative effectiveness of erenumab versus oral preventive medications among migraine patients: A US claims database study

Assessment of the pharmacokinetics of co‐administered maraviroc and raltegravir

Predictive value of early magnetic resonance imaging measures is differentially affected by the dose of interferon beta-1a given subcutaneously three times a week: an exploratory analysis of the PRISMS study

Hemodynamic effects of single-dose vardenafil in subjects receiving maraviroc

Pharmacokinetic interactions between lersivirine and zidovudine, tenofovir disoproxil fumarate/ emtricitabine and abacavir/lamivudine

Potent protection of ferulic acid against excitotoxic effects of maternal intragastric administration of monosodium glutamate at a late stage of pregnancy on developing mouse fetal brain

33991 Predictors of response to secukinumab in patients with moderate to severe plaque psoriasis with special area involvement in real-world clinical setting: A pooled analysis of prospective observational studies PROSPECT, SERENA, and REALIA

Uncontrolled asthma across GINA treatment steps 2 − 5 in a large US patient cohort

Real-world treatment satisfaction with erenumab in migraine: analysis of the US National Health and Wellness Survey

P254 Secukinumab retention and safety in patients with active psoriatic arthritis or ankylosing spondylitis: two-year interim results of the observational SERENA study

Employee and Employer Benefits From a Migraine Management Program: Disease Outcomes and Cost Analysis

Effectiveness of erenumab and onabotulinumtoxinA on acute medication usage and health care resource utilization as migraine prevention in the United States

Comparison of pharmacokinetic variability of fesoterodine vs. tolterodine extended release in cytochrome P450 2D6 extensive and poor metabolizers

Early MRI results and odds of attaining ‘no evidence of disease activity’ status in MS patients treated with interferon β-1a in the EVIDENCE study

Correction to: Real-World Trends in Characteristics of Patients with Migraine Newly Initiated on Erenumab in the USA: A Retrospective Analysis

Health Care Utilization and Costs in Patients With Migraine Who Have Failed Previous Preventive Treatments

Correction to: Real-World Trends in Characteristics of Patients with Migraine Newly Initiated on Erenumab in the USA: A Retrospective Analysis

Suchergebnisse filtern